Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome

  • T. Glauser
    From Cincinnati Children’s Hospital (T.G.), Cincinnati, OH; BHZ Vogtareuth (G. Kluger), Germany; Princeton and Rutgers Neurology (R.S.), Princeton, NJ; Johns Hopkins Medical Center (G. Krauss), Baltimore, MD; and Eisai Global Clinical Development (C.P., S.A.), Ridgefield Park, NJ.
  • G. Kluger
    From Cincinnati Children’s Hospital (T.G.), Cincinnati, OH; BHZ Vogtareuth (G. Kluger), Germany; Princeton and Rutgers Neurology (R.S.), Princeton, NJ; Johns Hopkins Medical Center (G. Krauss), Baltimore, MD; and Eisai Global Clinical Development (C.P., S.A.), Ridgefield Park, NJ.
  • R. Sachdeo
    From Cincinnati Children’s Hospital (T.G.), Cincinnati, OH; BHZ Vogtareuth (G. Kluger), Germany; Princeton and Rutgers Neurology (R.S.), Princeton, NJ; Johns Hopkins Medical Center (G. Krauss), Baltimore, MD; and Eisai Global Clinical Development (C.P., S.A.), Ridgefield Park, NJ.
  • G. Krauss
    From Cincinnati Children’s Hospital (T.G.), Cincinnati, OH; BHZ Vogtareuth (G. Kluger), Germany; Princeton and Rutgers Neurology (R.S.), Princeton, NJ; Johns Hopkins Medical Center (G. Krauss), Baltimore, MD; and Eisai Global Clinical Development (C.P., S.A.), Ridgefield Park, NJ.
  • C. Perdomo
    From Cincinnati Children’s Hospital (T.G.), Cincinnati, OH; BHZ Vogtareuth (G. Kluger), Germany; Princeton and Rutgers Neurology (R.S.), Princeton, NJ; Johns Hopkins Medical Center (G. Krauss), Baltimore, MD; and Eisai Global Clinical Development (C.P., S.A.), Ridgefield Park, NJ.
  • S. Arroyo
    From Cincinnati Children’s Hospital (T.G.), Cincinnati, OH; BHZ Vogtareuth (G. Kluger), Germany; Princeton and Rutgers Neurology (R.S.), Princeton, NJ; Johns Hopkins Medical Center (G. Krauss), Baltimore, MD; and Eisai Global Clinical Development (C.P., S.A.), Ridgefield Park, NJ.

書誌事項

公開日
2008-05-20
DOI
  • 10.1212/01.wnl.0000303813.95800.0d
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

収録刊行物

  • Neurology

    Neurology 70 (21), 1950-1958, 2008-05-20

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ